BenevolentAI | Investor Conference Presentation Deck | 29 slides

BenevolentAI · 2023-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

29
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
summarize
Open slide detailBeat · Attention
04
establish_context
Open slide detailBeat · Attention
05
The central diagram represents a knowledge graph or network of interconnected biological data points.present_framework
Open slide detailBeat · Attention
06
The slide uses a process flow diagram to explain the platform's methodology.present_framework
Open slide detailBeat · Interest
07
The slide features a screenshot of a software platform with a zoomed-in callout box showing a data table of mechanisms related to ALS.other
Open slide detailBeat · Interest
08
The slide shows a UI screenshot of a 'BenevolentAI' platform. It highlights a 'PPI Edge Details' modal window.other
Open slide detailBeat · Interest
09
The central diagram acts as a template for hypothesis generation: 'Can we treat [Target] by [Sign] [Mechanism] in [Cell type] by [Sign] [Mechanism]?'present_framework
Open slide detailBeat · Interest
10
The diagram shows a process flow from data inputs to model processing to target identification.present_solution
Open slide detailBeat · Interest
11
The slide uses a combination of UI screenshots and a list of benefits to illustrate the platform's capabilities.present_solution
Open slide detailBeat · Desire
12
The slide highlights a 'Triage criteria' panel with sliders for Biological Rationale, Ligandability, Safety, Tissue Expression, and Therapeutic Evidence.present_framework
Open slide detailBeat · Desire
13
The slide shows a UI screenshot with a zoomed-in callout highlighting the 'Literature' tab and evidence table.present_solution
Open slide detailBeat · Desire
14
The slide uses a hub-and-spoke visual metaphor to connect various lab functions to the central facility.present_solution
Open slide detailBeat · Desire
15
summarize
Open slide detailBeat · Desire
16
The chart uses a segmented bar approach to compare established industry players against BenevolentAI's projected output.compare_peers
Open slide detailBeat · Action
17
The slide uses a hub-and-spoke style diagram to show how a central platform feeds into four different commercialization strategies.present_framework
Open slide detailBeat · Action
18
The chart uses a timeline-like structure to show drug development stages from Target ID to Phase II.present_solution
Open slide detailBeat · Action
19
The slide uses a two-column layout to contrast the disease burden (left) with the proposed therapeutic solution (right).frame_problem
Open slide detailBeat · ActionLoop · Cost Of Inaction
20
Includes specific caveats regarding study power and dosing duration.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
21
The slide uses a split-column layout to contrast the disease burden/market need (left) with the proposed solution/mechanism (right).diagnose_problem
Open slide detailBeat · Action
22
The slide uses a process diagram to show the experimental workflow (biopsy to culture to measurement) followed by bar charts showing cytokine reduction.analyze_data
Open slide detailBeat · Action
23
The slide uses a combination of a horizontal timeline and a three-column process breakdown.plan_implementation
Open slide detailBeat · Action
24
The chart shows a horizontal bar representation of drug development stages. Some programs are marked with AstraZeneca partnership logos and dates.analyze_data
Open slide detailBeat · Action
25
The slide uses a split-layout with a summary of the partnership on the left and a timeline of expansion on the right.illustrate_case
Open slide detailBeat · ActionLoop · Before After
26
The slide is split into two main sections: a case study on baricitinib (left) and a partnership overview with DNDi (right).illustrate_case
Open slide detailBeat · Action
27
introduce_nominees
Open slide detailBeat · Action
28
plan_implementation
Open slide detailBeat · Action
29
Neon-style text effect on a dark blue background.summarize
Open slide detailBeat · Action